← Eichor
Study identifier: NCT05678023 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study About Contrast Media

Condition: Small Bowel Obstruction  ·  Sponsor: University of Tartu

PhaseNA
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.

This description comes directly from the study's public registry record.

Talk to the study team

Liis Jaanimäe, MD  ·  +3725224012  ·  liis.jaanimae@kliinikum.ee

Ceith Nikkolo, PhD  ·  ceith.nikkolo@kliinikum.ee

Always discuss trial participation with your own doctor first.

Locations (1)

Tartu University HospitalTartu, Tartu, EstoniaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05678023